Spyglass Pharma Inc's Comment on Sales, Marketing and Customers
The company serves customers including Ambulatory Surgery Centers (ASCs) by promoting the benefits of ophthalmic product candidates and anticipated coverage and reimbursement. Its markets encompass ophthalmic indications broadly, with a focus on chronic eye conditions. The company aims to expand patient access and explore new therapeutic areas through strategic partnerships. The team has experience with products reimbursed under Medicare Part B and therapies for retinal diseases. Specific ophthalmic products associated with the team include Beovu, Durysta, Izervay, KDB, Latisse, Lucentis PFS, Ozurdex, Refresh eye drops, Systane Ultra, Travatan Z, and Vuity. Customers and markets mentioned in filings include Astoria Health Investors, Gilde Healthcare, New Enterprise Associates, RA Capital Management, Samsara BioCapital, Sands Capital, Vensana Capital, and Vertex Ventures HC.
Spyglass Pharma Inc’s Comment on Sales, Marketing and Customers
The company serves customers including Ambulatory Surgery Centers (ASCs) by promoting the benefits of ophthalmic product candidates and anticipated coverage and reimbursement. Its markets encompass ophthalmic indications broadly, with a focus on chronic eye conditions. The company aims to expand patient access and explore new therapeutic areas through strategic partnerships. The team has experience with products reimbursed under Medicare Part B and therapies for retinal diseases. Specific ophthalmic products associated with the team include Beovu, Durysta, Izervay, KDB, Latisse, Lucentis PFS, Ozurdex, Refresh eye drops, Systane Ultra, Travatan Z, and Vuity. Customers and markets mentioned in filings include Astoria Health Investors, Gilde Healthcare, New Enterprise Associates, RA Capital Management, Samsara BioCapital, Sands Capital, Vensana Capital, and Vertex Ventures HC.
Sources:
Spyglass Pharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Spyglass Pharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Spyglass Pharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
